Xie et al. further studied the role of SLC16A1 in melanoma and found that the expression of SLC16A1 was up-regulated in metastatic melanoma and was associated with poor prognosis and immune cell infiltration [43]. The gene discussed is SLC16A1; the disease is metastatic melanoma.